Fig 1: Conversion of human SMCs toward endothelial-like cells through short term dedifferentiation using reprogramming factors. (a) Schematic protocol of the conversion of SMCs towards endothelial-like cells. SMCs were transfected with lentivirus vector containing the four reprogramming factors Oct4, Sox2, Klf4, c-Myc and then maintained in the reprogramming media for 4 days. Partially reprogrammed SMCs (PR-SMCs) were then differentiated towards endothelial lineage by culturing with endothelial-inductive condition. (b) Real-time PCR showed the induction of the four reprogramming factors at the mRNA level of PR-SMCs. Control group refers to the SMCs transfected with empty lentivirus vector and maintained under the same reprogramming conditions. (***p < 0.001 by Student’s t test, n = 4) (c) Real-time PCR showed an upregulation of progenitor marker CD34 in PR-SMCs. (***p < 0.001 by Student’s t test, n = 4) (d) Flow cytometry analysis of CD34 positive cells in PR-SMC population. (*p < 0.05 by Student’s t test, n = 3) (e) Real-time PCR results revealed an overall induction of the endothelial markers CD31, CD144, eNOS, vWF and Claudin5 (CLDN5) at the mRNA level in SMC-derived endothelial like cells (SMC-ECs). (*p < 0.05, ***p < 0.001 by Student’s t test, n = 5). Control group refers to the SMC transfected with empty lentiviral vector that underwent the same reprogramming and differentiation protocol. (f) Representative images of the immunofluorescence staining for CD31 of SMC-ECs. (Scale Bar: 25 μm) (g) Western blot analysis showed the expression of CD31 and CD144 at the protein level of SMC-ECs. (h) By immunofluorescence staining, white arrows indicated the cells that started to express vWF were the cells that lost the typical filamentous αSMA expression in the SMC-ECs population. (Scale bar: 25 μm) (i) Flow cytometry analysis exhibited increased CD31, CD34 expression in SMC-ECs compared to control group. Western blots were cropped for clarity. Examples of uncropped blots are found in Supplementary Figure 15.
Fig 2: Expression of CCL17 and CCL22 is increased in VCAT from morbidly obese patients. Relative quantification of mRNA levels for (A) CCL17 and (B) CCL22. Comparisons between groups were made by Wilcoxon matched-pair signed-rank test. Values are expressed as mean ± SEM (n = 33). (C) CCL17 and (D) CCL22 chemokine release into conditioned media was determined after 48 h of SCAT and VCAT explant culture. Chemokine secretion is expressed as pg/ml in the supernatant. Values are expressed as mean ± SEM (n = 22). Comparison between groups were made by Mann Whitney test. (E) Immunofluorescence representative images showing colocalization of CCL17 with CD3 (lymphocytes), CD31 (endothelial cells) and Mac-3 (macrophages); or CCL22 with CD3, CD31, Mac-3 in VCAT. Immunoreactivity was visualized using Alexa Fluor 594 (CCL17 and CCL22, red) and Alexa Fluor 488 (CD31, CD3, Mac-3, green) secondary antibodies. Nuclei were stained with Hoechst (blue). Scale bar, 20 μm. Nuclei were stained with Hoechst (blue).
Fig 3: Skin-on-chip contains a stratified epidermis and dermis with a functional microvascular network.a, b Schematics of the major components in native human skin and skin-on-chip. c Representative 3-D reconstructed confocal image showing an overview of the cytoskeleton of the micro-engineered epidermis and dermis with underlying endothelialized microvascular network (white arrow indicates microfluidic flow direction). F-actin for cell cytoskeleton (green), DAPI for cell nucleus (blue). d Representative 3-D reconstructed confocal image illustrating basale (bottom, K14+) and corneous (upper, anucleate) layers in the epidermis of skin-on-chip. F-actin (green), K14 (red), DAPI (blue). Scale bar: 20 µm. e A cross-sectional view of hematoxylin–eosin (H&E) stained epidermis in the skin-on-chip. Scale bar: 20 µm. f Maximum intensity projected confocal image of an endothelialized microvascular network in the dermis after two weeks of culturing. F-actin (green), DAPI (blue). Scale bar: 100 µm. g Projected confocal images showing endothelium marker (CD31) expression, lumen formation (yz), and fibroblast capping of endothelial vessel (bottom). CD31 (green), Vimentin (red), DAPI (blue). Scale bar: 100 µm. h Representative fluorescence image after perfusion with 40 kDa FITC-Dextran through the microvasculature for 20 min. Graph depicts fluorescence intensity across the microvasculature inside the dashed box at 7 min (red) and 10 min after perfusion (blue). Scale bar: 100 µm. i F-actin cytoskeleton arrangement in endothelial cells and related flow shear force. Right: enlarged view within the white boxes. Scale bar: 100 µm. j Representative confocal image showing new sprouting from the main vessel lumen after angiogenetic stimuli. Right image shows cross-sectional view (yz). CD31 (green), Vimentin (red), DAPI (blue). Scale bar: 100 µm. Data are provided in a Source data file.
Fig 4: Snail induces stemness properties and endothelium generation of breast cancer cells through Sox2.a qRT-PCR analysis of relative mRNA expression of Sox2 in MCF-7 and ZR75-1 cells stably infected with lentivirus carrying EV or Snail. b qRT-PCR analysis of relative mRNA expression of Sox2 in MCF-7 and ZR75-1 cells transfected with control siRNA or Snail siRNA. c Representative FACS of MCF-7 cells infected with the indicated plasmids CD44-FITC and CD24-PE. Statistical analysis of CD24−/CD44+ rates is shown in the right panel. Results shown are mean ± SD of three independent experiments. d Mammosphere assay of MCF-7 cells infected with indicated plasmids. Graphs show the relative number of mammospheres. Results shown are mean ± SD of three independent experiments. Scale bar, 20 μm. e qRT-PCR analysis of relative mRNA expression of endothelium markers VEGFR2, CD31, and CD105 in MCF-7 and ZR75-1 cells stably infected with the indicated plasmids. f FACS analysis of MCF-7 cells infected with indicated plasmids using CD31-FITC antibodies. Statistical analysis of CD31+ rates is shown in the right panel. Results shown are mean ± SD of three independent experiments. g Representative confocal images of MCF-7 cells infected with the indicated plasmids labelled with endothelium markers CD31 and VWF. The nuclei were stained with DAPI (blue). Scale bar, 20 μm. Graphs show the percentage of endothelium marker-positive cells. Results shown are mean ± SD of three independent experiments. h Lineage tracing of MCF-7 cells stably infected with EV or Snail using CD31pro-GFP, CD105pro-GFP, or CD144pro-GFP. Scale bar, 10 μm. Graphs show the percentage of GFP-positive cells. Results shown are mean ± SD of three independent experiments. i Tube-forming assays and DiI-AcLDL uptake assays with Snail-copGFP-expressing or copGFP-expressing MCF-7 cells. Statistical analysis of tube length is shown in the right panel. Results shown are mean ± SD of three independent experiments. Scale bar, 100 μm. Red: DiI-AcLDL staining. *P < 0.05, **P < 0.01.
Fig 5: Protein expression of PCNA and CD31. *P<0.05 and **P<0.01 vs. the control group on the same day. C refers to the control group; M refers to the bronchopulmonary dysplasia (BPD) model group.
Supplier Page from Abcam for Anti-CD31 antibody